Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVMD | AZN | AMGN | GILD | BMY |
| Company | Revolution Medicines Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 148.80 | 184.37 | 330.39 | 136.50 | 56.44 |
| High | 149.79 | 184.37 | 331.28 | 136.50 | 56.90 |
| Low | 144.00 | 182.08 | 327.31 | 134.62 | 55.57 |
| Latest | 144.27 | 182.14 | 328.09 | 135.31 | 55.76 |
| Change | -6.80 | -2.78 | -3.02 | -0.99 | -0.83 |
| % Change | -4.50% | -1.50% | -0.91% | -0.73% | -1.47% |
| Volume | 599,683 | 274,161 | 290,342 | 1,295,833 | 2,449,385 |
| 20-Day Average Volume | 4,619,455 | 1,950,695 | 2,505,683 | 5,386,479 | 9,749,357 |
| Previous Close | 151.07 | 184.92 | 331.11 | 136.30 | 56.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 141.40 | 192.70 | 342.26 | 134.32 | 58.30 |
| 20-Day Raw Stochastic | 81.90% | 8.63% | 20.47% | 51.02% | 4.99% |
| 20-Day Relative Strength | 61.22 | 39.28 | 39.39 | 47.94 | 41.83 |
| Weighted Alpha | +123.57 | +26.96 | +17.01 | +32.43 | +19.31 |
| Today's Opinion | 100% Buy | 8% Buy | 8% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 100% Buy | 8% Buy | 8% Sell | 24% Buy | 24% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 40% Buy | 56% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.36% since 04/30/26 | -2.68% since 04/30/26 | -5.25% since 04/30/26 | +3.30% since 04/30/26 | -7.86% since 04/30/26 |
| Low | 139.39 on 05/01/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 129.01 on 05/01/26 | 55.57 on 05/07/26 |
| High | 151.43 on 05/06/26 | 187.18 on 05/01/26 | 337.00 on 05/01/26 | 136.75 on 05/06/26 | 60.08 on 05/01/26 |
| 1-Month | |||||
| %Chg | +50.22% since 04/07/26 | -9.19% since 04/07/26 | -3.51% since 04/07/26 | -2.62% since 04/07/26 | -3.19% since 04/07/26 |
| Low | 94.63 on 04/10/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 155.70 on 04/16/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +48.37% since 02/06/26 | -5.53% since 02/06/26 | -14.63% since 02/06/26 | -11.37% since 02/06/26 | -9.94% since 02/06/26 |
| Low | 91.52 on 03/30/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.57 on 05/07/26 |
| High | 155.70 on 04/16/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +137.08% since 11/07/25 | +7.80% since 11/07/25 | +2.46% since 11/07/25 | +13.73% since 11/07/25 | +19.58% since 11/07/25 |
| Low | 61.50 on 11/10/25 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 155.70 on 04/16/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,116,428 | 286,793,888 | 178,695,104 | 169,178,560 | 115,560,800 |
| Shares Outstanding, K | 212,593 | 1,550,908 | 539,685 | 1,241,222 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -1,131,300,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -364,890,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.41 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.29 on 05/06/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/06/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.57 | 14.91 | 16.38 | 9.60 |